학술논문

Efficacy and Safety of Open-Label Setmelanotide in Bardet-Biedl Syndrome: a Phase 3 Trial
Document Type
Journal
Source
OBESITY; DEC 2021, 29 p12-p12, 1p. Supplement: 2
Subject
Language
English
ISSN
1930739X